https://european-biotechnology.net/wp-content/uploads/2024/11/NOD-Proteindesign.Andreas-HeddergottTUM-1030x579-1.png
579
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-11-22 07:18:252024-12-05 15:02:03New method set to speed up protein design
https://european-biotechnology.net/wp-content/uploads/2024/11/Certest-e1732098332654-1030x580-1.jpg
580
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-11-20 10:27:532024-12-05 15:02:03Circio Holding ASA inks collaboration agreement with Certest Biotec SL
https://european-biotechnology.net/wp-content/uploads/2024/11/EB424_Agricouncil_Consilium_tg-scaled-e1732031435528-1030x580-1.jpg
580
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-11-19 16:04:062024-11-19 16:04:06Country alliance calls for EU protein strategy
https://european-biotechnology.net/wp-content/uploads/2024/10/Scotland-1030x618-1.jpg
618
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-11-19 05:17:342024-11-19 05:17:34ATB Therapeutics raises €54m in Series A financing
https://european-biotechnology.net/wp-content/uploads/2024/11/Innate-Pharma-ANKET-tg-1030x423-1.png
423
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-11-16 06:01:122024-11-16 06:01:12Tetraspecific B/NK cell better than T cell engagers
https://european-biotechnology.net/wp-content/uploads/2024/11/Adaptimmune-TCR_T-e1731568031629.jpg
434
770
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-11-14 07:23:262024-11-14 07:23:26Adaptimmune nears second approval for TCR-T therapy
https://european-biotechnology.net/wp-content/uploads/2024/11/Exosome-signalling-1030x515-1.jpg
515
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-11-13 08:47:472024-11-13 08:47:47Pharmahungary Group participates in ambitious EU EVEREST Project
https://european-biotechnology.net/wp-content/uploads/2024/11/Alentis-1030x458-1.jpg
458
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-11-13 08:00:462024-11-13 08:00:46Alentis Therapeutics raises US$181.4m in Series D financing
https://european-biotechnology.net/wp-content/uploads/2024/11/GeldLSP-1030x782-1.jpg
782
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-11-12 06:30:482024-11-12 06:30:48Alentis Therapeutics raises US$181.4m in Series D financing
https://european-biotechnology.net/wp-content/uploads/2024/11/PEGS-Plenary-Panel-Discussion-1030x776-1.png
776
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-11-11 14:40:402024-11-11 14:40:40Next-gen antibody formats presented at PEGS Europe
Scroll to top
